Accelerated Approval Reform Proposals Worry Industry: ‘Science Doesn’t Move The Same Way’

 
• By Derrick Gingery
  
Cartier Esham at House Energy and Commerce Health Subcommittee
BIO's Cartier Esham testifies about accelerated approval and other FDA reforms during a House Energy and Commerce Health Subcommittee hearing. • Source: screenshot

More from Review Pathways

More from Pathways & Standards